Description

WELLlife COVID-19 / Influenza A&B Test is a rapid immunoassay designed for the qualitative detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B using a single nasal swab. This CLIA-waived point-of-care (POC) test enables fast and reliable identification of respiratory infections, supporting timely clinical decisions.

Utilizing advanced immunoassay technology, this multiplex test provides accurate results in a short timeframe, making it suitable for hospitals, clinics, urgent care centers, and other healthcare environments during flu season and public health response scenarios.

Key Features

• Multiplex rapid antigen test for COVID-19, Flu A, and Flu B
• CLIA-waived for point-of-care use
• Single nasal swab collection
• Rapid and reliable results
• Supports efficient respiratory infection screening
• Designed for professional healthcare settings

Specifications

Test Type: Rapid Antigen Test
Format: Immunoassay
Detection: SARS-CoV-2, Influenza A, Influenza B
Use: Professional Use (POC)
Pack Size: 25 tests per box
Case Configuration: 450 tests per case (18 boxes)
NDC Number: Not Available

Kit Contents

• 25 Test cassettes
• 25 Prefilled extraction buffer tubes
• 25 Sterile swabs
• Positive external control swab (Flu A, B, and COVID)
• Negative external control swab (Flu A, B, and COVID)

Applications

Point-of-Care Testing
Respiratory Infection Screening
Clinical Diagnostics
Healthcare Facilities